Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
5,725,862
-
Shares change
-
-130,691
-
Total reported value, excl. options
-
$919,195,735
-
Value change
-
-$21,822,779
-
Put/Call ratio
-
2.01%
-
Number of buys
-
86
-
Number of sells
-
-112
-
Price
-
$160.5
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2021
266 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q1 2021.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,725,862 shares
.
Largest 10 shareholders include MORGAN STANLEY (938,660 shares), WELLS FARGO & COMPANY/MN (610,737 shares), BANK OF AMERICA CORP /DE/ (537,392 shares), UBS Group AG (396,176 shares), LPL Financial LLC (332,990 shares), ROYAL BANK OF CANADA (242,404 shares), RAYMOND JAMES & ASSOCIATES (206,837 shares), Raymond James Financial Services Advisors, Inc. (203,797 shares), ADVISOR GROUP HOLDINGS, INC. (169,653 shares), and COMMONWEALTH EQUITY SERVICES, LLC (145,473 shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.